The ability of thissystemically active NGF mimetic to protect pancreatic β-cells is ofpractical importance, because this compound is currently being investigated asa treatment for strokes, and the “coexistence” of stroke anddiabetes is well established [50]. This evidence concerns the gene NGF and stroke disorder.